...
首页> 外文期刊>Journal of Medicinal Chemistry >Opioid Binding and in Vitro Profiles of a Series of 4-Hydroxy-3-methoxyindolomorphinans. Transformation of a δ-Selective Ligand into a High Affinity κ-Selective Ligand by Introduction of a 5,14-Substituted Bridge
【24h】

Opioid Binding and in Vitro Profiles of a Series of 4-Hydroxy-3-methoxyindolomorphinans. Transformation of a δ-Selective Ligand into a High Affinity κ-Selective Ligand by Introduction of a 5,14-Substituted Bridge

机译:阿片类药物的结合和一系列4-羟基-3-甲氧基吲哚吗啡的体外特征。通过引入5,14取代的桥将δ选择性配体转变为高亲和力κ选择性配体

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In investigation of the effects of 14-substitution in the indolomorphinan series of δ-selective opioid ligands, 5,14-bridged indolomorphinans (4) were prepared from the equivalent dihy-drothebainone acid-catalyzed rearrangement products of the dihydrothevinols. Though the new ligands generally had low affinity for opioid receptors and no δ-selectivity, 4b had high κ-affinity and substantial selectivity which was also seen in the precursor morphinanone (3b). This indicates that the methylbenzylidene-substituted bridge in these compounds is a dominant κ-opioid receptor binding motif.
机译:在对吲哚吗啡系列δ选择性阿片样物质配体中14位取代的影响进行研究时,由等效的二氢巯基丁酮酸催化的二氢乙烯醇的重排产物制备了5,14桥联的吲哚吗啡喃(4)。尽管新的配体通常对阿片样物质受体的亲和力低且无δ选择性,但4b的κ亲和力高且选择性高,这在前体吗啡酮(3b)中也可见。这表明这些化合物中的甲基亚苄基取代的桥是主要的κ-阿片受体结合基序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号